Xcout Intel
Inflammatix, Inc.
Inflammatix, Inc. is a molecular diagnostics and biotechnology research company headquartered in Sunnyvale, California. It develops rapid point-of-care host-response diagnostic tests for suspected acute infections or sepsis.
Subscribe to see Inflammatix, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Inflammatix, Inc. at a glance
Inflammatix, Inc. is a diagnostics company headquartered in United States. Its most recent funding round, Series E, raised $57M in September 2024. Xcout tracks 17 named people at Inflammatix, Inc., including Steve Tablak (Former Chairman and CEO, GeneWeave).
Inflammatix, Inc. leadership
- Steve TablakFormer Chairman and CEO, GeneWeave
- Martín VazquezChief Operating Officer
- Joao FonsecaChief Technology Officer
- Jamie LewisChief Commercial Officer
- Tim SweeneyCo-Founder and CEO
- Purvesh KhatriCo-Founder and Chief Scientist
11 more named people on record for Inflammatix, Inc., with roles, board committees and tenure — see the full roster →
Inflammatix, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series E | $57M | 5 named | |
| SEC Form D filing | $102.4M | — | |
| SEC Form D filing | $32.1M | — | |
| Series E | $32.1M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Inflammatix, Inc. competitors
A few of Inflammatix, Inc.'s closest competitors — see the full list of competitors and alternatives →
Day Zero Diagnostics is a biotechnology company developing rapid, sequencing-based diagnostic tests to identify bloodstream infections and predict antimicrobial resistance. Its products are intended for hospitals and clinicians managing seriously ill patients who need faster pathogen identification and antibiotic-selection information.
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. is a Chinese in-vitro diagnostics company that develops and manufactures rapid immunodiagnostic and molecular diagnostic products, including infectious-disease testing kits. Its customers include clinical laboratories, hospitals, public-health organizations, and diagnostic distributors.
InBios International, Inc. is a biotechnology research and diagnostic company located in Seattle, Washington. The firm specializes in the design and development of innovative, superior-quality diagnostic products for infectious diseases.
HelixBind, Inc. is a medical diagnostics company headquartered in Boxborough, Massachusetts. The company specializes in technologies for the rapid identification of bloodstream infections.
Seegene provides molecular diagnostics products and technologies, including high-multiplex syndromic assays, automated instruments, and software systems. The company serves global healthcare and research partners by offering diagnostic solutions and a data platform for infectious disease detection and surveillance.
Edifice Health, Inc., formerly known as IUVE, Inc., is a Silicon Valley-based emerging company headquartered in San Mateo, California. The company specializes in immunological health, focusing on the detection and measurement of systemic chronic inflammation.
Get Inflammatix, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Inflammatix, Inc. in Xcout Intel
- 17 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access